Literature DB >> 15845578

Inhibition of sarcoplasmic reticular function by chronic interleukin-6 exposure via iNOS in adult ventricular myocytes.

Xin-Wen Yu1, Qian Chen, Richard H Kennedy, Shi J Liu.   

Abstract

Interleukin (IL)-6 has been shown to decrease cardiac contractility via a nitric oxide synthase (NOS)-dependent pathway during acute exposure. We previously reported that IL-6 decreases contractility and increases inducible NOS (iNOS) in adult rat ventricular myocytes (ARVM) after 2 h exposure. The goal of this study was to investigate the cellular mechanism underlying this chronic IL-6-induced negative inotropy and the role of iNOS. Pretreatment for 2 h with 10 ng ml-1 IL-6 decreased the kinetics of cell shortening (CS) and contractile responsiveness to Ca2+o ([Ca2+]o from(0) to 2 mM) in ARVM. We first examined whether IL-6 reduced Ca2+ influx via L-type Ca2+ -channel current (ICa,L). Whole-cell ICa,L in ARVM was measured under conditions similar to those used for CS measurements, and it was found to be unaltered by IL-6. The sarcoplasmic reticular (SR) function was then assessed by examining postrest potentiation (PRP) and caffeine responsiveness of CS. Results showed that treatment with IL-6 for 2 h significantly decreased PRP, which was concomitant with a decrease in the phosphorylation of phospholamban. Following removal of IL-6, PRP and responsiveness to 10 mM caffeine were also reduced. Meanwhile, the IL-6-induced increase in nitric oxide (NO) production after 2 h (but not 1 h) was abolished by NG-monomethyl-l-arginine (l-NMMA) and 2-amino-5,6-dihydro-6-methyl-4H-1,3-thiazine (AMT; a selective inhibitor of iNOS). Furthermore, IL-6-elicited suppressions of PRP and responsiveness to caffeine and Ca2+o were abolished by L-NMMA and AMT. Thus, these results suggest that activation of iNOS mediates IL-6-induced inhibition of SR function in ARVM during chronic exposure.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15845578      PMCID: PMC1464756          DOI: 10.1113/jphysiol.2005.086686

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  61 in total

Review 1.  Nitric oxide and cardiac function: ten years after, and continuing.

Authors:  P B Massion; O Feron; C Dessy; J-L Balligand
Journal:  Circ Res       Date:  2003-09-05       Impact factor: 17.367

2.  Interleukin-6 causes myocardial failure and skeletal muscle atrophy in rats.

Authors:  Sofie P M Janssen; Ghislaine Gayan-Ramirez; An Van den Bergh; Paul Herijgers; Karen Maes; Erik Verbeken; Marc Decramer
Journal:  Circulation       Date:  2005-02-14       Impact factor: 29.690

Review 3.  Interleukin-6 family of cytokines and gp130.

Authors:  T Kishimoto; S Akira; M Narazaki; T Taga
Journal:  Blood       Date:  1995-08-15       Impact factor: 22.113

4.  JAK2/STAT3, not ERK1/2, mediates interleukin-6-induced activation of inducible nitric-oxide synthase and decrease in contractility of adult ventricular myocytes.

Authors:  XinWen Yu; Richard H Kennedy; Shi J Liu
Journal:  J Biol Chem       Date:  2003-02-20       Impact factor: 5.157

5.  Nitric oxide-dependent parasympathetic signaling is due to activation of constitutive endothelial (type III) nitric oxide synthase in cardiac myocytes.

Authors:  J L Balligand; L Kobzik; X Han; D M Kaye; L Belhassen; D S O'Hara; R A Kelly; T W Smith; T Michel
Journal:  J Biol Chem       Date:  1995-06-16       Impact factor: 5.157

6.  Relaxation in rabbit and rat cardiac cells: species-dependent differences in cellular mechanisms.

Authors:  J W Bassani; R A Bassani; D M Bers
Journal:  J Physiol       Date:  1994-04-15       Impact factor: 5.182

7.  Nitric oxide regulation of myocardial contractility and calcium cycling: independent impact of neuronal and endothelial nitric oxide synthases.

Authors:  Shakil A Khan; Michel W Skaf; Robert W Harrison; Kwangho Lee; Khalid M Minhas; Anil Kumar; Mike Fradley; Artin A Shoukas; Dan E Berkowitz; Joshua M Hare
Journal:  Circ Res       Date:  2003-05-22       Impact factor: 17.367

8.  Nitric oxide-mediated effects of interleukin-6 on [Ca2+]i and cell contraction in cultured chick ventricular myocytes.

Authors:  K Kinugawa; T Takahashi; O Kohmoto; A Yao; T Aoyagi; S Momomura; Y Hirata; T Serizawa
Journal:  Circ Res       Date:  1994-08       Impact factor: 17.367

9.  Nitric oxide donor SIN-1 inhibits mammalian cardiac calcium current through cGMP-dependent protein kinase.

Authors:  G M Wahler; S J Dollinger
Journal:  Am J Physiol       Date:  1995-01

10.  G protein-mediated suppression of L-type Ca2+ current by interleukin-1 beta in cultured rat ventricular myocytes.

Authors:  S Liu; K D Schreur
Journal:  Am J Physiol       Date:  1995-02
View more
  11 in total

1.  Minocycline reverses IL-17A/TRAF3IP2-mediated p38 MAPK/NF-κB/iNOS/NO-dependent cardiomyocyte contractile depression and death.

Authors:  Tadashi Yoshida; Nitin A Das; Andrea J Carpenter; Reza Izadpanah; Senthil A Kumar; Sandeep Gautam; Shawn B Bender; Ulrich Siebenlist; Bysani Chandrasekar
Journal:  Cell Signal       Date:  2020-06-15       Impact factor: 4.315

2.  Skeletal muscle function during the progression of cancer cachexia in the male ApcMin/+ mouse.

Authors:  Brandon N VanderVeen; Justin P Hardee; Dennis K Fix; James A Carson
Journal:  J Appl Physiol (1985)       Date:  2017-11-09

3.  Lipopolysaccharide and cytokines inhibit rat cardiomyocyte contractility in vitro.

Authors:  Ion A Hobai; Justin C Morse; Deborah A Siwik; Wilson S Colucci
Journal:  J Surg Res       Date:  2014-09-22       Impact factor: 2.192

4.  Absence of SOCS3 in the cardiomyocyte increases mortality in a gp130-dependent manner accompanied by contractile dysfunction and ventricular arrhythmias.

Authors:  Toshitaka Yajima; Yoshiteru Murofushi; Hanbing Zhou; Stanley Park; Jonathan Housman; Zhao-Hua Zhong; Michinari Nakamura; Mitsuyo Machida; Kyung-Kuk Hwang; Yusu Gu; Nancy D Dalton; Tomoko Yajima; Hideo Yasukawa; Kirk L Peterson; Kirk U Knowlton
Journal:  Circulation       Date:  2011-11-14       Impact factor: 29.690

5.  Both cGMP and peroxynitrite mediate chronic interleukin-6-induced negative inotropy in adult rat ventricular myocytes.

Authors:  Xin-Wen Yu; Meei-Yueh G Liu; Richard H Kennedy; Shi J Liu
Journal:  J Physiol       Date:  2005-05-05       Impact factor: 5.182

Review 6.  The role of TWEAK/Fn14 in cardiac remodeling.

Authors:  Man-Yi Ren; Shu-Jian Sui
Journal:  Mol Biol Rep       Date:  2012-06-30       Impact factor: 2.316

7.  TNF-alpha and IL-1beta increase Ca2+ leak from the sarcoplasmic reticulum and susceptibility to arrhythmia in rat ventricular myocytes.

Authors:  David J Duncan; Zhaokang Yang; Philip M Hopkins; Derek S Steele; Simon M Harrison
Journal:  Cell Calcium       Date:  2010-03-12       Impact factor: 6.817

Review 8.  The crossroads of inflammation, fibrosis, and arrhythmia following myocardial infarction.

Authors:  Samantha D Francis Stuart; Nicole M De Jesus; Merry L Lindsey; Crystal M Ripplinger
Journal:  J Mol Cell Cardiol       Date:  2015-12-29       Impact factor: 5.000

9.  Interleukin-6 displays lung anti-inflammatory properties and exerts protective hemodynamic effects in a double-hit murine acute lung injury.

Authors:  Guillaume Voiriot; Keyvan Razazi; Valérie Amsellem; Jeanne Tran Van Nhieu; Shariq Abid; Serge Adnot; Armand Mekontso Dessap; Bernard Maitre
Journal:  Respir Res       Date:  2017-04-19

10.  Interleukin-6-Mediated-Ca2+ Handling Abnormalities Contributes to Atrial Fibrillation in Sterile Pericarditis Rats.

Authors:  Jie Liao; Shaoshao Zhang; Shuaitao Yang; Yang Lu; Kai Lu; Yuwei Wu; Qiongfeng Wu; Ning Zhao; Qian Dong; Lei Chen; Yimei Du
Journal:  Front Immunol       Date:  2021-12-16       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.